BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Lupin Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500257
ISIN Demat
INE326A01037
Book Value (Rs)
659.0470742
NSE Symbol
LUPIN
Divident Yield %
0.72
Market Cap
(Rs In Cr.)
113,933
P/E (TTM)
18.89
EPS (TTM)
131.91
Face Value
(Rs)
2
Back
Lupin receives Establishment Inspection Report for its Ankleshwar unit
28-May-26   Hrs IST

Lupin today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Ankleshwar facility in Gujarat, India, following closure of a product specific Pre-Approval Inspection from 02 March to 07 March 2026.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)